George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not really a pump if they've sold assets to a value greater than current mkt cap. Is it?
Er, see above where it says RNS? Jeez
Can anyone tell me what's happening here?
And the first pump and dumper of the LSE has arrived :-))
200% of yesterday mcap....this is going higher here today
I like the bit about returning cash to the shareholders
As I mentioned previously Xlm is so undervalued. The sale of the non core slower moving assets for $35m implies with quite some confidence the us business, which is generating more revenue, and has a much higher growth trajectory could be valued north of $40/50m, so this underpins my confidence that this share is going to 17p and potentially 25p sometime soon!! DYOR obviously nfa
Yep, I’m all out too. Lost a bit but no dramas. Won’t be buying back either. The BOD have decimated SH value here whilst, IMO, looking after themselves. This one doesn’t sit right with me.
GLA.
At 10p, thank you buyers. What a suprise this one is, out with a nice profit. Dont think I will be buying back again, good luck to all
Ah sorry, couldn’t see it. 👍🏼
Read #rns lol sale of assets
Anyone know what’s going on here?
Net income for the first half was $4.7M. That's from an "adjusted EBIDTA" of $6.5M.
They are projecting a FY adjusted EBIDTA of $12M, so $5.5 from H2.
But lets be super conservative and say that this $5.5M of adjusted EBIDTA translates to 0 of actual net income.
So that's a net income of $4.7M, or ~£3.9M, vs a Market Cap of £16.6, giving a PE of ~4.3, ASSUMING NO INCOME IN H2.
What on earth??
OK, it's not continuing to grow explosively after NY opened up; OK it looks like a while until the next big state opens up. But $50M of revenues is perfectly respectable, they have no debt, and they only have max $7.5M more deferred acquisition payments to make.
Why is this so cheap? What am I missing??
Hospitals have still got plenty of patients
Just looking back at JammyC share buy picks a year ago .
This one along with RGBP,SAGA ,PXC, THS .
All well down 3 more then 50% .
As poor as my own lossers .
Peakybinder... last year.
No one has any patients these days...Buy your shares now and sell in 1,2, or 3 years.....
My guess then is 60-80p if not more.. Gla
That's a big buy at the end of the day. Hopefully someone knows something...
Just reread the December TU and today’s results, both revenue and ebitda, come in at the low end of the ranges given in that update, _after_ taking into account the trading disruption announced. So certainly a lackluster performance, yet again.
Some management competence I suspect. Whilst this looks cheap, there is absolutely nothing to suggest the sp won’t keep dropping like it has done for years, and profit gradually eroded.
There’s no new information here. We know there aren’t many state launches lined up. They already told us about the issues with Barstool. “Consolidation” is exactly what we need - continue operating, signing partnership deals, and ideally more revenue share agreements. No more expensive purchases of websites, no more overhauling of the business model. Meanwhile the valuation is ridiculous. I don’t understand what the market expects of this share!
Nothing to expect from this year then. Sigh. Unless they manage to get a decent offer but highly doubtful with the sp sat at 6p.
Where is the floor then? As poor as this is, we still did @£41m rev and £10m ebitda. We’re valued @£17m. 🤷🏻♂️
At last Caroline is going. Can we get the business moving now guys, and providing clear progress updates? Thanks.
Here is a response from the IR company Vigo Consulting. Communication skills are obviously not a job requirement
Thank you for your email regarding XLMedia.
Apologies for the ambiguity in the announcement of the 27 July 2023. I can confirm that the only asset sold was the Personal Finance business. Reef Media was rationalised and retains a small number of profitable clients, and Blueclaw Media ceased to provide marketing services to external clients, but continues to provide services internally.
I hope this provides greater clarity and if you have any further questions, please don’t hesitate to let me know.
Kind regards,
Fiona
Can anyone explain this to me? Last July in the trading update the board announced "We have exited non-core activities including the sale of the loss-making Personal Finance business, Reef Media and Blueclaw which contributed US$0.6 million revenue (H1 2022: US$2.1 million)."
Why are Caroline Ackroyd and David King still directors? This is from Companies House: hxxps://find-and-update.company-information.service.gov.uk/company/05985341/officers. Did they sell Blueclaw to themselves?
Although I share your view that this is way too cheap, I don’t share your optimism otherwise. Every single RNS is dull and dreary and that’s if they can make it make any sense. Yet they won’t sell with the share price where it is. What do they expect? They could try buying a few themselves but no.
This was once a £300m company. Now it’s on the bones of its ass. I’d take 15p and move on.
I've just added another 20k, it's far to cheap and will bounce hard next year with everything else.. Gla